Login

Pierre Laurin, CEO, ProMetic Life Sciences Inc 00:00:00

Share On Facebook Share On Twitter

Pierre Laurin of ProMetic gives a summary of the company's drug development platform

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
These fuel assemblies remain in the reactor core for several years, providing a steady source of energy|Tom Drivas, President & CEO, Appia Energy Corp
00:10:00
Revolutionizing Fan Experience with Omni-Channel Retail and JP Morgan Payments
00:00:00
Onconova Therapeutics featured on Worldwide Business - Dr. Steven Fruchtman, CEO, Onconova Therapeutics Inc
00:10:00
Barian Mining: New Gold Exploration Ventures in Nevada
00:10:00
Face to Face with the Bulls - Fábio and Ronaldo Cury | Fabio Cury - CEO of Cury Construtora e Incorporadora SA
00:10:00
The Executive Director of The Naga Group AG discusses Cyprus as an ideal business location for ICT companies at the Invest Cyprus Roadshow (The Americas).
00:10:00
Wildfire Prevention and Mitigation Investment Lead at Convective|Bill Clerico,Managing Partner, Convective Capital
00:10:00
Alberto Mario Griselli, CEO of TIM S.A., discusses the transformation in the Brazilian telecommunications market and its impact on TIM.
00:10:00
Nedbank CIB's Naväge Singh on Strategic Mining Investments and Financing
00:10:00
Kate Richard on Oil Market Dynamics and Investment Strategies at Warwick Energy | Kate Richard, Founder and CEO, Warwick Energy Group.
00:10:00
Cohen & Steers: Expanding Leadership in Global Real Assets | Bob Steers, Executive Chairman , Cohen & Steers Inc.
00:10:00
Ville Kangasmuukko on Bubbleroom's IPO Plans and E-commerce Strategy | Ville Kangasmuukko, CEO, New Bubbleroom Sweden AB.

© 2026 Nehu